Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia

• Status: Withdrawn
• Trial end date: 2020-07-31

Summary

The purpose of this study is to investigate the safety of a test drug to treat hemophilia in adult men.

• Phase: Phase 1

Details

• Lead Sponsor: Bayer
• Treatments: Antibodies; Antibodies, Monoclonal; Immunoglobulin G; Immunoglobulins; Lipoprotein-associated coagulation inhibitor; Myeloma Proteins; Paraproteins; Thromboplastin